Advertisement
Valcyte Coupon - Valcyte 450mg tablet

Valganciclovir

VALGANCICLOVIR is an antiviral medicine. It is used to treat or prevent infections caused by certain kinds of viruses. It is commonly used to treat and prevent cytomegalovirus (CMV) infections of the eye and body. The lowest GoodRx price for the most common version of valganciclovir is around $534.20, 76% off the average retail price of $2,264.91. Compare CMV nucleoside analogues.
Valcyte Coupon - Valcyte 450mg tablet

Valcyte Latest News

Get the latest updates on this drug from the GoodRx medical team

50+ Drugs Dropped by Insurance in 2016, Including Viagra and Qsymia

Elizabeth Davis - August 12, 2015

It’s that time again—the new lists of covered and excluded drugs on next year’s insurance plans are out, and it doesn’t look great. For many Americans with health insurance, more than 50 popular brand-name and generic drugs may no longer be covered starting in January 2016.

Express Scripts and Caremark, companies that handles pharmacy benefits for more than 200 million Americans, are removing about 20 – 30 drugs each from their national preferred formularies at the end of 2015. See More

New FDA Approved Generic: Valcyte

Roni Shye - November 24, 2014

After a long wait, generic Valcyte (valganciclovir) has been approved and will be available soon! For more information on why the generic was delayed, see our previous post here.

Valcyte is used for the prevention and treatment of cytomegalovirus (CMV). CMV is a common virus related to the family of viruses that cause chickenpox, herpes simplex, and mono.

There is no cure for CMV—once you have been infected, the virus will be in your body for life. See More

Hoping for Cheaper Nexium and Valcyte? You May Be Waiting a While Longer

Elizabeth Davis - November 07, 2014

The FDA has revoked two tentative generic drug approvals from manufacturer Ranbaxy Laboratories, for heartburn med Nexium (esomeprazole magnesium) and antiviral Valcyte (valganciclovir). Ranbaxy has had tentative approval to make these generics since 2008, but the final approvals were delayed due to long-standing issues with quality and compliance.

Earlier this year, the FDA banned all output from Ranbaxy’s India-based facilities due to quality concerns (see our previous post here), leaving only their New Jersey plant to produce highly anticipated generics like valsartan (generic Diovan). See More

GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.
In all states except Tennessee, GoodRx is considered a marketer of prescription discount cards, and is not required to register as a discount card provider. In Tennessee, GoodRx is registered as a Prescription Drug Discount Plan Operator.
Safe Pharmacy